Randamu accepted into WTIA Founder's Cohort 10
Washingtoner/10232608

SEATTLE - Washingtoner -- Randamu, a premier web3 platform for trustworthy computing, is excited to announce their acceptance as one of only ~25% of applicants to be admitted to Washington Technology Industry Association (WTIA) Founder's Cohort 10. WTIA is the unifying voice for the technology community in Washington state, representing over 1,100 companies and 300,000 tech workers. Now in it's tenth iteration, the Founder's Cohort is a six-month program that provides mentorship, education, and peer support to early-stage startups with founders and employees headquartered in Washington State.

"We expect to face numerous challenges as an up-and-coming web3 infrastructure company..." noted Erick Watson, Co-Founder & CEO of Randamu. "...WTIA's Founder's Cohort will help us in overcoming many of these."

Such challenges include:

• Expanding their loyal customer base in a highly competitive market
• Continuing to build out their scalable and reliable technology platform
• Securing seed funding and strategic partnerships to support their growth
• Navigating various legal and regulatory issues across multiple jurisdictions

Being accepted into WTIA Founder's Cohort, Randamu expects to achieve the following results:

• Access to a network of experienced mentors and advisors who can provide guidance and feedback
• Exposure to potential investors, customers, and partners through events and showcases
• Education on topics such as fundraising, marketing, product development, and leadership
• Peer support from other founders who share similar challenges and opportunities

"Part of WTIA's charter is to strengthen our local startup ecosystem..." notes Koki Sato of WTIA. "...helping web3 companies such as Randamu get off to a strong start is an essential part of what our programs are designed to address."

More on Washingtoner

• Shiokly Launches Online Marketplace to Help Singapore Home-Based Businesses Sell More, With First Product Listed Free
• Freight Broker 911 and Milton Collier Introduce "What's The 911?"—A New Podcast Built on Real Talk, Real Freight, and Real Opportunity
• PropAccount.com Launches PropWallet, Turning Prop Firm Payouts Into Repeat Sales
• Spokane: City And County Seek Federal Grant to Plan for Road Network Wildfire Resilience
• The Great Junk Hunt Returns to Monroe: Kick Off Your Holiday Shopping at the Ultimate Vintage Treas

Randamu believes that participating in WTIA Founder's Cohort will help them overcome challenges and accelerate growth. They hope to leverage the resources and connections provided by WTIA to create unique and valuable services for their clients. Randamu is excited to join the cohort and contribute to the vibrant tech community in Washington state.

About Randamu

Randamu enables trustworthiness in decentralized applications. Our products overcome challenges for clients in blockchain, gaming, lotteries, casinos and more. We're backed by over 20 institutions through the League of Entropy consortium.

About WTIA

Washington Technology Industry Association (WTIA) is a consortium that includes a not-for-profit member trade association, a not-for-profit tech apprenticeship intermediary (Apprenti), and a for profit corporation providing business services (HRBI). The organization's mission is to foster a robust, equity-centered technology sector that empowers thriving communities. We recruit technology companies and allies that view diversity as a competitive advantage, value collaboration as essential to sustainable growth, and fully embrace the opportunity to partner with and empower the communities in which we operate.

More on Washingtoner

• AI Trading Agents Track Aerospace and Defense US Stocks Amid Rising Technology Investment (SATS, GILT, TSAT, IREN, JOBY, LUNR)
• KOLBUS America, For All Of Your Hycorr Equipment And Service Needs
• Evluma's RoadMax Edge Roadway Luminaires Earn DarkSky Approved Status
• Heritage at Hopewell Announces New 3.875% Year-One Mortgage Rate Buydown Incentive on Quick Delivery Townhomes (7.11% APR)
• New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc